ArticleClinical hypertension2025

Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study.

Jinho Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.